VK-8 was used in experiments that ultimately led to the cloning of MUC16 [6,21] and the OC125 antibody was used as a reagent to establish the clinical-grade CA125 assay to measure the concentration of this marker in the sera of cancer patients [22,23]. Here, MUC16 is linked to cancer.